DPM is a high-end medical device and innovative medical technology provider specializing in intraoperative precise optical molecular imaging products and technologies. The company develops and provides comprehensive intraoperative molecular imaging navigation solutions and services. Its product focus centers on surgical optical molecular imaging to guide procedures. The article reports that DPM recently completed a financing round exceeding RMB 200 million. The financing is described as a C round. Participating investors named in the report include Daohe Zhiyi, Huiding Investment, and Yunqi Investment, with Huaxing Capital serving as exclusive financial advisor.

Total raised

$28M

Funding rounds

1

Latest round

Series C

Latest activity

Jan 2024